EP1572069A4 - Facteurs de protection contre des inflammations, des brulures et des stimuli nocifs - Google Patents

Facteurs de protection contre des inflammations, des brulures et des stimuli nocifs

Info

Publication number
EP1572069A4
EP1572069A4 EP02765303A EP02765303A EP1572069A4 EP 1572069 A4 EP1572069 A4 EP 1572069A4 EP 02765303 A EP02765303 A EP 02765303A EP 02765303 A EP02765303 A EP 02765303A EP 1572069 A4 EP1572069 A4 EP 1572069A4
Authority
EP
European Patent Office
Prior art keywords
burns
noxious stimuli
against inflammation
protective factors
factors against
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP02765303A
Other languages
German (de)
English (en)
Other versions
EP1572069A2 (fr
Inventor
Uri Wormser
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yissum Research Development Co of Hebrew University of Jerusalem
Original Assignee
Yissum Research Development Co of Hebrew University of Jerusalem
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yissum Research Development Co of Hebrew University of Jerusalem filed Critical Yissum Research Development Co of Hebrew University of Jerusalem
Publication of EP1572069A2 publication Critical patent/EP1572069A2/fr
Publication of EP1572069A4 publication Critical patent/EP1572069A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EP02765303A 2001-08-29 2002-08-29 Facteurs de protection contre des inflammations, des brulures et des stimuli nocifs Withdrawn EP1572069A4 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IL145181A IL145181A0 (en) 2001-08-29 2001-08-29 Protective factors against burns and noxious stimuli
IL14518101 2001-08-29
PCT/IL2002/000713 WO2003017920A2 (fr) 2001-08-29 2002-08-29 Facteurs de protection contre des inflammations, des brulures et des stimuli nocifs

Publications (2)

Publication Number Publication Date
EP1572069A2 EP1572069A2 (fr) 2005-09-14
EP1572069A4 true EP1572069A4 (fr) 2009-06-24

Family

ID=11075745

Family Applications (1)

Application Number Title Priority Date Filing Date
EP02765303A Withdrawn EP1572069A4 (fr) 2001-08-29 2002-08-29 Facteurs de protection contre des inflammations, des brulures et des stimuli nocifs

Country Status (4)

Country Link
EP (1) EP1572069A4 (fr)
AU (1) AU2002329017A1 (fr)
IL (1) IL145181A0 (fr)
WO (1) WO2003017920A2 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005090387A2 (fr) * 2004-03-23 2005-09-29 Yissum Research Development Company Of The Hebrew University Of Jerusalem Derives de peptide d'histone h2a et analogues, et methodes d'utilisation
US7528227B2 (en) 2004-03-23 2009-05-05 Yissum Research Development Company Of The Hebrew University Of Jerusalem Histone H2A peptide derivatives and uses thereof
US7605132B2 (en) 2001-08-29 2009-10-20 Yissum Research Development Company Of The Hebrew University Of Jerusalem Protective factors against inflammation, burns and noxious stimuli
WO2006101187A1 (fr) * 2005-03-22 2006-09-28 Rohto Pharmaceutical Co., Ltd. Peptide qui augmente la production de collagene ou d’acide hyaluronique
WO2011128884A1 (fr) 2010-04-11 2011-10-20 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Extrait et peptides dérivés du groupe oryza sativa japonica et leurs utilisations
CN106397575A (zh) * 2016-10-20 2017-02-15 上海懿贝瑞生物医药科技有限公司 一种具有胞外组蛋白毒性抑制作用的多肽制备方法及用途

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2750920A1 (de) * 1977-11-15 1979-05-17 Max Planck Gesellschaft Arzneimittel zur behandlung von pathologischen prozessen
WO1995028946A1 (fr) * 1994-04-25 1995-11-02 The Scripps Research Institute Methodes et compositions d'inhibition de l'inflammation induite par les cellules endotheliales et le fibrinogene
WO2000064466A1 (fr) * 1999-04-28 2000-11-02 Northwestern University Localisation d'autoepitopes de peptides majeurs pour lymphocytes t nucleosomes specifiques de lupus erythemateux aigu dissemine
WO2001038522A1 (fr) * 1999-11-23 2001-05-31 Bioroad Gene Development Ltd. Shanghai Nouveau polypeptide, histone humaine h2a.21, et polynucleotide codant pour ce polypeptide

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030007964A1 (en) * 1998-01-24 2003-01-09 Samyang Genex Corporation Method for treating rheumatoid arthritis with composition containing histone

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2750920A1 (de) * 1977-11-15 1979-05-17 Max Planck Gesellschaft Arzneimittel zur behandlung von pathologischen prozessen
WO1995028946A1 (fr) * 1994-04-25 1995-11-02 The Scripps Research Institute Methodes et compositions d'inhibition de l'inflammation induite par les cellules endotheliales et le fibrinogene
WO2000064466A1 (fr) * 1999-04-28 2000-11-02 Northwestern University Localisation d'autoepitopes de peptides majeurs pour lymphocytes t nucleosomes specifiques de lupus erythemateux aigu dissemine
WO2001038522A1 (fr) * 1999-11-23 2001-05-31 Bioroad Gene Development Ltd. Shanghai Nouveau polypeptide, histone humaine h2a.21, et polynucleotide codant pour ce polypeptide

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
DATABASE UniProt [online] 1 January 1990 (1990-01-01), "RecName: Full=Fibrinogen alpha chain; Contains: RecName: Full=Fibrinopeptide A; Flags: Fragment;", XP002527672, retrieved from EBI accession no. UNIPROT:P14445 Database accession no. P14445 *
JORGENSEN P H ET AL: "Mechanical strength in rat skin incisional wounds treated with fibrin sealant", JOURNAL OF SURGICAL RESEARCH, ACADEMIC PRESS INC., SAN DIEGO, CA, US, vol. 42, no. 3, 1 March 1987 (1987-03-01), pages 237 - 241, XP023022408, ISSN: 0022-4804, [retrieved on 19870301] *
SALTZ R ET AL: "Experimental and clinical applications of fibrin glue.", PLASTIC AND RECONSTRUCTIVE SURGERY DEC 1991, vol. 88, no. 6, December 1991 (1991-12-01), pages 1005 - 1015 ; di, XP009116793, ISSN: 0032-1052 *

Also Published As

Publication number Publication date
AU2002329017A1 (en) 2003-03-10
IL145181A0 (en) 2009-02-11
WO2003017920A3 (fr) 2006-08-10
EP1572069A2 (fr) 2005-09-14
WO2003017920A2 (fr) 2003-03-06
AU2002329017A8 (en) 2006-11-09

Similar Documents

Publication Publication Date Title
HUP0401065A3 (en) Protective appliance against insects and its use
IL159015A0 (en) Polypeptides, their preparation and use
GB2386376B (en) Protein-silane/siloxane copolymers, their preparation and their use
HK1061212A1 (en) Pyranoindazoles and their use for the treatment ofglaucoma
HK1078266A1 (en) Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and the use of the same
IL162137A0 (en) D-ribofuranosylthiazolo -3-Ä4,5-dÜpyridimine nucl eosides and uses thereof
HK1083831A1 (en) Indazoles, benzothiazoles, and benzoisothiazoles, and preparation and uses thereof
HRP20040027A2 (en) 1-phenylsulfonyl-1,3-dihydro-2h-indole-2-one derivatives, their preparation and their therapeutic use
PL366142A1 (en) Hydroprocessing catalyst and use thereof
EP1469860A4 (fr) Combinaison anticancereuse et son utilisation
EP1368051A4 (fr) Urocortine iii et certaines de ses utilisations
EP1210084A4 (fr) Pyridomorphinanes, thienomorphinanes et utilisation
IL158397A0 (en) Polypeptides, their preparation and their use
TW529846U (en) Over-current protection component and the device
GB2395952B (en) Block copolymer and use thereof
AU2003215257A8 (en) Modified defensins and their use
IL161472A0 (en) In vitro micro-organs, and uses related thereto
AU2002361337A8 (en) Amphoteric polysaccharide, composition and use
ZA200210316B (en) Composition and its therapeutic use.
AU2003298129A8 (en) Floor-furnace chimney and the use thereof
EP1558238A4 (fr) Beta-hydroxyphenylaldylamines et utilisation de celles-ci pour traiter le glaucome
HK1048724A2 (en) Hair former and hair former attachment
AU2002329017A8 (en) Protective factors against inflammation, burns and noxious stimuli
HUP0600238A2 (en) Benzothiazole- and benzoxazole-4,7-dione derivatives and their use
HUP0202377A3 (en) N-substituted perhydrodiazines, preparation and use thereof

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20040301

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LI LU MC NL PT SE SK TR

AX Request for extension of the european patent

Extension state: AL LT LV MK RO SI

PUAK Availability of information related to the publication of the international search report

Free format text: ORIGINAL CODE: 0009015

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 38/04 20060101AFI20061009BHEP

A4 Supplementary search report drawn up and despatched

Effective date: 20090528

17Q First examination report despatched

Effective date: 20090901

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20120301